Total Payments
$7,473
2024 Payments
$2,215
Companies
56
Transactions
299
Medicare Patients
365
Medicare Billing
$70,934
Payment Breakdown by Category
Food & Beverage$5,510 (73.7%)
Education$1,265 (16.9%)
Other$697.90 (9.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,510 | 279 | 73.7% |
| Education | $1,265 | 13 | 16.9% |
| Long term medical supply or device loan | $697.90 | 7 | 9.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,259 | 47 | $0 (2024) |
| Janssen Biotech, Inc. | $619.40 | 40 | $0 (2024) |
| Genentech USA, Inc. | $580.01 | 18 | $0 (2019) |
| Lilly USA, LLC | $485.60 | 8 | $0 (2020) |
| Astellas Pharma US Inc | $385.71 | 11 | $0 (2019) |
| Amgen Inc. | $359.56 | 23 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $295.27 | 16 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $260.02 | 11 | $0 (2024) |
| TESARO, Inc. | $245.85 | 8 | $0 (2019) |
| PFIZER INC. | $245.20 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,215 | 71 | Novartis Pharmaceuticals Corporation ($754.46) |
| 2023 | $95.72 | 2 | AstraZeneca Pharmaceuticals LP ($73.60) |
| 2022 | $167.50 | 6 | Seagen Inc. ($81.99) |
| 2021 | $54.11 | 3 | Celgene Corporation ($20.77) |
| 2020 | $337.93 | 12 | Lilly USA, LLC ($207.01) |
| 2019 | $1,570 | 89 | Genentech USA, Inc. ($388.04) |
| 2018 | $2,020 | 85 | Novartis Pharmaceuticals Corporation ($278.78) |
| 2017 | $1,013 | 31 | TESARO, Inc. ($171.64) |
All Payment Transactions
299 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $18.99 | General |
| 12/12/2024 | Incyte Corporation | MONJUVI (Drug) | Food and Beverage | Cash or cash equivalent | $24.46 | General |
| Category: Oncology | ||||||
| 12/11/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 11/22/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $26.48 | General |
| 11/14/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: Oncology | ||||||
| 11/06/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $28.42 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/04/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Oncology | ||||||
| 11/01/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Food and Beverage | In-kind items and services | $29.87 | General |
| Category: ONCOLOGY | ||||||
| 10/25/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/21/2024 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: HEMATOLOGY | ||||||
| 10/18/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 10/16/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: ONCOLOGY | ||||||
| 10/14/2024 | ARRAY BIOPHARMA INC | XALKORI (Drug), LORBRENA, BRAFTOVI | Food and Beverage | In-kind items and services | $25.58 | General |
| Category: ONCOLOGY | ||||||
| 10/11/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $25.49 | General |
| Category: Oncology | ||||||
| 10/04/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: ONCOLOGY | ||||||
| 09/27/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 09/27/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.05 | General |
| 09/27/2024 | ABBVIE INC. | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: ONCOLOGY | ||||||
| 09/19/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $21.92 | General |
| Category: Oncology | ||||||
| 09/18/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $72.56 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/18/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $17.09 | General |
| Category: Hematology | ||||||
| 09/12/2024 | GENZYME CORPORATION | CABLIVI (Biological), ENJAYMO | Food and Beverage | In-kind items and services | $29.90 | General |
| Category: Hematology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 99 | 160 | $53,508 | $13,277 |
| 2022 | 5 | 123 | 413 | $134,307 | $32,849 |
| 2021 | 4 | 132 | 265 | $85,169 | $23,403 |
| 2020 | 1 | 11 | 16 | $4,528 | $1,405 |
Total Patients
365
Total Services
854
Medicare Billing
$70,934
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 34 | 73 | $23,141 | $5,006 | 21.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 35 | 51 | $16,167 | $3,995 | 24.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $8,823 | $2,420 | 27.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 13 | 19 | $5,377 | $1,856 | 34.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 65 | 326 | $103,342 | $24,297 | 23.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 21 | 38 | $10,754 | $3,069 | 28.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 20 | $9,120 | $2,398 | 26.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 13 | 13 | $6,227 | $1,796 | 28.8% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 12 | 16 | $4,864 | $1,289 | 26.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 68 | 171 | $54,207 | $14,027 | 25.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 39 | 69 | $19,527 | $5,759 | 29.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 14 | 14 | $7,266 | $2,299 | 31.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $4,169 | $1,318 | 31.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 11 | 16 | $4,528 | $1,405 | 31.0% |
About Dr. Sameeksha Bhama, M.D
Dr. Sameeksha Bhama, M.D is a Internal Medicine healthcare provider based in Frisco, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/02/2013. The National Provider Identifier (NPI) number assigned to this provider is 1699018234.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sameeksha Bhama, M.D has received a total of $7,473 in payments from pharmaceutical and medical device companies, with $2,215 received in 2024. These payments were reported across 299 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($5,510).
As a Medicare-enrolled provider, Bhama has provided services to 365 Medicare beneficiaries, totaling 854 services with total Medicare billing of $70,934. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Hematology & Oncology
- Location Frisco, TX
- Active Since 04/02/2013
- Last Updated 04/22/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1699018234
Products in Payments
- KISQALI (Drug) $983.63
- CYRAMZA (Drug) $364.47
- TECENTRIQ (Biological) $353.22
- IMBRUVICA (Drug) $348.63
- DARZALEX (Biological) $279.33
- KEYTRUDA (Biological) $233.60
- ZEJULA (Drug) $233.27
- INJECTAFER (Drug) $176.66
- OPDIVO (Biological) $153.24
- Revlimid (Drug) $146.44
- Nplate (Biological) $133.04
- Imbruvica (Drug) $124.58
- XTANDI (Drug) $118.82
- ALIMTA (Drug) $111.19
- Rituxan (Biological) $103.68
- Avastin (Biological) $102.73
- NINLARO (Drug) $91.36
- TAGRISSO (Drug) $86.74
- Kyprolis (Biological) $83.21
- CELLEXXTS PHOTOPHERESIS SYSTEM (Device) $79.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Frisco
Jasbir Dhawan, Md, MD
Internal Medicine — Payments: $320,303
Internal Medicine $320,303
Jason Riehs, Md, MD
Internal Medicine — Payments: $201,897
Internal Medicine $201,897
Dr. Naveen Sikka, M.d, M.D
Internal Medicine — Payments: $96,322
Internal Medicine $96,322
Dr. Sibi Thomas, D.o, D.O
Internal Medicine — Payments: $75,591
Internal Medicine $75,591
Stephanie Berg, Md, MD
Internal Medicine — Payments: $42,134
Internal Medicine $42,134
Ramesh Amara, Md, MD
Internal Medicine — Payments: $13,128
Internal Medicine $13,128